Bookmark

Add to MyYahoo RSS

ImmunoGen News

News on ImmunoGen (Ticker: IMGN) continually updated from thousands of sources around the net.

Tuesday Apr 8 | Business Wire

ImmunoGen, Inc. Announces First Clinical Findings with Refined Dosing Strategy for IMGN853

The data were presented at the American Association for Cancer Research Annual Meeting in San Diego, CA.

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry

Mon Apr 07, 2014

AmericanBankingNews.com

Immunogen Rating Increased to Outperform at Zacks

The firm currently has a $15.90 target price on the stock. Zacks 's price objective suggests a potential upside of 19.64% from the company's previous close.

Comment?

Related Topix: ImmunoGen, Biotech, Medicine, Healthcare Industry

Thu Mar 20, 2014

Hispanic Business

ImmunoGen Schedules Presentations by Company Scientists at Upcoming AACR Annual Meeting

"They also include highly encouraging preclinical findings with both our IMGN289 and IMGN853 compounds, as well as data on some of the more recent additions to our ADC technology portfolio."

Comment?

Related Topix: ImmunoGen, Biotech, Medicine, Healthcare Industry, Pharmacology

Tue Mar 18, 2014

AmericanBankingNews.com

Immunogen CEO Sells $246,000 in Stock

Immunogen CEO Daniel M. Junius sold 15,000 shares of the stock on the open market in a transaction that occurred on Monday, March 17th.

Comment?

Related Topix: Biotech, Medicine, ImmunoGen, Healthcare Industry

Mon Mar 17, 2014

Hispanic Business

ImmunoGen, Inc. Announces Presentations by Company Scientists at Upcoming AACR Annual Meeting

'The presentations scheduled include the pharmacokinetics modeling work which informed our decision to dose IMGN853 based on adjusted ideal body weight and to assess it dosed weekly,' commented , Ph.D., Executive Vice President and Chief Scientific Officer.

Comment?

Related Topix: ImmunoGen, Biotech, Medicine, Healthcare Industry

•••
•••
•••
•••
•••

Seattle Jobs

•••
•••
•••
•••
•••